Standard BioTools(FRA) FLB

Market Cap€219.84M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€0.56

+1.82%

+0.01Today

Standard BioTools Financials at a Glance

Market Cap

€219.84M

Revenue (TTM)

€72.54

Net Income (TTM)

-€46.18

EPS (TTM)

-€0.19

P/E Ratio

-2.90

Dividend

€0.00

Beta (Volatility)

0.15 (Low)

Dividend

€0.00

Beta (Volatility)

0.15 (Low)

Price

€0.56

Volume

1,000

Open

€0.56

Price

€0.56

Volume

1,000

Open

€0.56

Previous Close

€0.56

Daily Range

€0.56 - €0.56

52-Week Range

€0.54 - €1.42

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.15 (Low)

Price

€0.56

Volume

1,000

Open

€0.56

Previous Close

€0.56

Daily Range

€0.56 - €0.56

52-Week Range

€0.54 - €1.42

Estimated Earnings Date

N/A

FLB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Standard BioTools

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

389

CEO

Michael Egholm, PhD

Website

www.standardbio.com

FLB Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-11.08%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-34.48%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€219.84M

Shares Outstanding

392.58M

Volume

1.00K

Avg. Volume

24.242

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Standard BioTools Performance Analysis

Standard BioTools annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 93,197,330	-15.6%
2023	2023-12-31	EUR 98,361,359	5.5%
2024	2024-12-31	EUR 84,134,952	-14.5%
2025	2025-12-31	EUR 75,609,310	-10.1%

Standard BioTools annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -2.31	249.3%
2023	2023-12-31	EUR -0.87	-62.2%
2024	2024-12-31	EUR -0.48	-44.5%
2025	2025-12-31	EUR -0.17	-64.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€17.29

+0.9%

Gross Profit

€9.06

+1.0%

Gross Margin

52.40%

+1.1%

Market Cap

€219.84M

N/A

Market Cap/Employee

€0.65

N/A

Employees

389

N/A

Net Income

-€18.51

+1.2%

EBITDA

-€5.64

+0.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€260.75

+63.5%

Total Debt

€24.57

+1.0%

Accounts Receivable

€13.77

+1.1%

Inventory

€14.96

+0.7%

Long Term Debt

€19.65

+1.0%

Short Term Debt

€4.92

+1.1%

Return on Assets

-9.03%

+0.5%

Return on Invested Capital

-31.57%

+0.9%

Free Cash Flow

-€9.41

+0.5%

Operating Cash Flow

-€9.12

+0.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About FLB

What is the current price of Standard BioTools?

Standard BioTools is trading at €0.56 per share.

What is the 52-week range for Standard BioTools?

Over the past 52 weeks, Standard BioTools has traded between €0.54 and €1.42.

How much debt does Standard BioTools have?

As of the most recent reporting period, Standard BioTools reported total debt of €24.57M.

How much cash does Standard BioTools have on hand?

Standard BioTools reported €236.18M in cash and cash equivalents in its most recent financial results.

What is Standard BioTools’s dividend yield?

Standard BioTools does not currently have a dividend yield.

Standard BioTools(FRA) FLB

Standard BioTools Financials at a Glance

FLB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Standard BioTools

FLB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Standard BioTools Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FLB

What is the current price of Standard BioTools?

What is the 52-week range for Standard BioTools?

How much debt does Standard BioTools have?

How much cash does Standard BioTools have on hand?

What is Standard BioTools’s dividend yield?

Premium Investing Services